MVA-MUC1-IL2

Modified vaccinia Ankara vector expressing MUC1 and interleukin-2 · Transgene

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MVA-MUC1-IL2, covering 2006-11-02 to 2006-11-02. Get the full timeline:

Most recent: Clinical Trial Update: Vaccine Study of MVA-MUC1-IL2 in Patients With Prostate Cancer [Phase 2]